- The Sanofi–GSK COVID-19 vaccine, sold
under the
brand name
VidPrevtyn Beta, is a COVID-19
vaccine developed by
Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19...
-
Archived from the
original on 30
December 2021.
Retrieved 19
January 2022. "
VidPrevtyn Beta".
European Medicines Agency (EMA). 4
November 2022.
Archived from...
-
Zealand Turkey The Sanofi–GSK COVID-19 vaccine, sold
under the
brand name
VidPrevtyn Beta, is a
subunit vaccine developed by
Sanofi Pasteur and GSK plc. It...
-
Victoza Victrelis vidarabine (INN)
Vidaza Videx Videx Ec
vidofludimus (INN)
Vidprevtyn Beta
vidupiprant (INN)
Viekira Pak (Copackaged)
Viekira Xr
Viekira Viekirax...
- 20
December 2021 21
March 2022 VLA2001 24 June 2022 9
September 2022
VidPrevtyn Beta 10
November 2022 12
December 2022
Bimervax (COVID-19
Vaccine HIPRA)...
- old,
arriving in
Bulgaria in late
October 2022. On 10
November 2022,
VidPrevtyn Beta
received EMA's and the
European Commission's authorization, with...
-
response Pending authorization Sanofi–GSK COVID-19
vaccine (VAT00008,
Vidprevtyn)
Sanofi Pasteur, GSK France,
United Kingdom Subunit (SARS-CoV-2 S adjuvanted...
